|
1
|
Lee SY and Pearce EN: Hyperthyroidism: A
review. JAMA. 330:1472–1483. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang C, Li Y, Teng D, Shi X, Ba J, Chen B,
Du J, He L, Lai X, Li Y, et al: Hyperthyroidism prevalence in China
after universal salt iodization. Front Endocrinol (Lausanne).
12(651534)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Iglesias P, Benavent M, Lopez G, Arias J,
Romero I and Diez JJ: Hyperthyroidism and cardiovascular disease:
An association study using big data analytics. Endocrine.
83:405–413. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hiruma M, Watanabe N, Mitsumatsu T, Suzuki
N, Fukushita M, Matsumoto M, Yoshihara A, Noh JY, Sugino K and Ito
K: Clinical features of moyamoya disease with Graves' disease: A
retrospective study of 394,422 patients with thyroid disease.
Endocr J. 70:141–148. 2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lin Y, Guo R, Cao S, Gao G and Zeng Y:
Causal role of thyroid function in functional outcome after
ischemic stroke: A Mendelian randomization study. J Stroke
Cerebrovasc Dis. 33(108019)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang MH, Yang FY and Lee DD: Thyroid
disease as a risk factor for cerebrovascular disease. J Stroke
Cerebrovasc Dis. 24:912–920. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dekkers OM, Horvath-Puho E, Cannegieter
SC, Vandenbroucke JP, Sorensen HT and Jorgensen JO: Acute
cardiovascular events and all-cause mortality in patients with
hyperthyroidism: A population-based cohort study. Eur J Endocrinol.
176:1–9. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Manolis AA, Manolis TA, Melita H and
Manolis AS: Subclinical thyroid dysfunction and cardiovascular
consequences: An alarming wake-up call? Trends Cardiovasc Med.
30:57–69. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhang S, Yu H, Zhao Y, Gong A, Guan C,
Chen S, Xiao B and Lu J: Genetically predicted hypothyroidism,
thyroid hormone treatment, and the risk of cardiovascular diseases:
A mendelian randomization study. BMC Cardiovasc Disord.
24(479)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xu Y, Derakhshan A, Hysaj O, Wildisen L,
Ittermann T, Pingitore A, Abolhassani N, Medici M, Kiemeney LALM,
Riksen NP, et al: The optimal healthy ranges of thyroid function
defined by the risk of cardiovascular disease and mortality:
Systematic review and individual participant data meta-analysis.
Lancet Diabetes Endocrinol. 11:743–754. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Klein I and Danzi S: Thyroid disease and
the heart. Curr Probl Cardiol. 41:65–92. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kim K, Yang PS, Jang E, Yu HT, Kim TH, Uhm
JS, Kim JY, Sung JH, Pak HN, Lee MH, et al: Increased risk of
ischemic stroke and systemic embolism in hyperthyroidism-related
atrial fibrillation: A nationwide cohort study. Am Heart J.
242:123–131. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vidili G, Delitala A and Manetti R:
Subclinical hyperthyroidism: The cardiovascular point of view. Eur
Rev Med Pharmacol Sci. 25:3264–3271. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jeong SK, Seo JY, Nam HS and Park HK:
Thyroid function and internal carotid artery stenosis in ischemic
stroke. Endocr J. 57:711–718. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schwarz S, Schwab S, Klinga K, Maser-Gluth
C and Bettendorf M: Neuroendocrine changes in patients with acute
space occupying ischaemic stroke. J Neurol Neurosurg Psychiatry.
74:725–727. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang YJ, Zhang SM, Zhang L, Wang CX, Dong
Q, Gao S, Huang RX, Huang YN, Lv CZ, Liu M, et al: Chinese
guidelines for the secondary prevention of ischemic stroke and
transient ischemic attack 2010. CNS Neurosci Ther. 18:93–101.
2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Feigin VL, Krishnamurthi RV, Parmar P,
Norrving B, Mensah GA, Bennett DA, Barker-Collo S, Moran AE, Sacco
RL, Truelsen T, et al: Update on the global burden of ischemic and
hemorrhagic stroke in 1990-2013: The GBD 2013 study.
Neuroepidemiology. 45:161–176. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang Z, Ren Y, Liu W, Li J, Li J, Zhang C,
Wang L, Zhou M, Hao J, Yin P and Ma Q: National and subnational
trends of mortality and years of life lost due to stroke and its
subtypes in young adults in China, 2005-2020. Neurology.
103(e209982)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kim HJ, Kang T, Kang MJ, Ahn HS and Sohn
SY: Incidence and mortality of myocardial infarction and stroke in
patients with hyperthyroidism: A nationwide cohort study in Korea.
Thyroid. 30:955–965. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
ICD-9-CM: International classification of
diseases, 9th revision, clinical modification. 3d edition: volumes
1, 2 and 3. Official authorized addendum effective October 1,
1990-HCFA. J Am Med Rec Assoc 61: suppl 1-suppl35, 1990.
|
|
21
|
Messerli FH, Williams B and Ritz E:
Essential hypertension. Lancet. 370:591–603. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McCrimmon RJ, Ryan CM and Frier BM:
Diabetes and cognitive dysfunction. Lancet. 379:2291–2299.
2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen LY and Shen WK: Epidemiology of
atrial fibrillation: A current perspective. Heart Rhythm. 4:S1–S6.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Section of Interventional Cardiology of
Chinese Society of Cardiology; Section of Atherosclerosis and
Coronary Artery Disease of Chinese Society of Cardiology; Specialty
Committee on Prevention and Treatment of Thrombosis of Chinese
College of Cardiovascular Physicians. Guideline on the diagnosis
and treatment of stable coronary artery disease. Zhonghua Xin Xue
Guan Bing Za Zhi. 46:680–694. 2018.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
25
|
Jabbar A, Pingitore A, Pearce SH, Zaman A,
Iervasi G and Razvi S: Thyroid hormones and cardiovascular disease.
Nat Rev Cardiol. 14:39–55. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ruan W, Zhou X, Li J, Wang T, Liu H, Zhang
G and Lin K: Thyroid function effect on cardiac structure, cardiac
function, and disease risk: Evidence of causal associations in
European ancestry. Heart Rhythm. 21:2272–2281. 2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Leonards CO, Schneider HJ, Liman TG,
Fiebach JB, Endres M and Ebinger M: Thyroid-stimulating hormone,
white matter hyperintensities, and functional outcome in acute
ischemic stroke patients. Cerebrovasc Dis Extra. 4:61–68.
2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li LQ, Xu XY, Li WY, Hu XY and Lv W: The
prognostic value of total T3 after acute cerebral infarction is
age-dependent: A retrospective study on 768 patients. BMC Neurol.
19(54)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Hussein M, Toraih E, Reisner ASC, Miller
P, Corsetti R and Kandil E: Prevalence and mortality of
cardiovascular events in patients with hyperthyroidism: A
nationwide cohort study in the United States. Gland Surg.
10:2608–2621. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lin YS, Tsai HY, Lin CY, Wu VC, Chen TH,
Yang TY, Aboyans V and Chen M: Risk of thromboembolism in
non-valvular atrial fibrillation with or without clinical
hyperthyroidism. Global Heart. 16(45)2021.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Gu X, Li Y, Chen S, Yang X, Liu F, Li Y,
Li J, Cao J, Liu X, Chen J, et al: Association of lipids with
ischemic and hemorrhagic stroke: A prospective cohort study among
267 500 Chinese. Stroke. 50:3376–3384. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang X, Dong Y, Qi X, Huang C and Hou L:
Cholesterol levels and risk of hemorrhagic stroke: A systematic
review and meta-analysis. Stroke. 44:1833–1839. 2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Duntas LH: Thyroid disease and lipids.
Thyroid. 12:287–293. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Glasser SP, Mosher A, Howard G and Banach
M: What is the association of lipid levels and incident stroke? Int
J Cardiol. 220:890–894. 2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kotwal A, Cortes T, Genere N, Hamidi O,
Jasim S, Newman CB, Prokop LJ, Murad MH and Alahdab F: Treatment of
thyroid dysfunction and serum lipids: A systematic review and
meta-analysis. J Clin Endocrinol Metab. 105(dgaa672)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Murolo M, Di Vincenzo O, Cicatiello AG,
Scalfi L and Dentice M: Cardiovascular and neuronal consequences of
thyroid hormones alterations in the ischemic stroke. Metabolites.
13(22)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang X, Gong P, Sheng L, Lin Y, Fan Q,
Zhang Y, Bao Y, Li S, Du H, Chen Z, et al: Prognostic value of
subclinical thyroid dysfunction in ischemic stroke patients treated
with intravenous thrombolysis. Aging (Albany NY). 11:6839–6850.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wollenweber FA, Zietemann V, Gschwendtner
A, Opherk C and Dichgans M: Subclinical hyperthyroidism is a risk
factor for poor functional outcome after ischemic stroke. Stroke.
44:1446–1448. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Venditti P and Di Meo S: Thyroid
hormone-induced oxidative stress. Cell Mol Life Sci. 63:414–434.
2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Zhang X, Chen Z, Shi Z and Lou M:
Correlation between thyroid autoantibodies and intracranial
arterial stenosis in stroke patients with hyperthyroidism. J Neurol
Sci. 318:82–84. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang X, Zhou Y, Ding W, Zhang R, Yan S,
Deng Y, Gao F and Lou M: TPO-Ab plays a role in arterial remodeling
in patients with intracranial stenosis. Atherosclerosis.
280:140–146. 2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Franklyn JA, Maisonneuve P, Sheppard MC,
Betteridge J and Boyle P: Mortality after the treatment of
hyperthyroidism with radioactive iodine. N Engl J Med. 338:712–718.
1998.PubMed/NCBI View Article : Google Scholar
|
